[Safety evaluation of drugs on the cardiovascular system by the analysis of gene expression].
D000818:Animals; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000235:genetics; D002135:Calcium-Binding Proteins / Q000235:genetics; D000252:Calcium-Transporting ATPases / Q000235:genetics*; D002155:Calsequestrin / Q000235:genetics; D002312:Cardiomyopathy, Hypertrophic / Q000139:chemically induced* / Q000235:genetics*; D002319:Cardiovascular System / Q000187:drug effects*; D064420:Drug-Related Side Effects and Adverse Reactions; D015870:Gene Expression / Q000187:drug effects*; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009152:Mutagenicity Tests / Q000379:methods*; D009200:Myocardial Contraction / Q000235:genetics; D009206:Myocardium / Q000166:cytology; D012519:Sarcoplasmic Reticulum / Q000502:physiology; D000099211:Phospholamban
D002118:Calcium; D015220:Calcium Channels; D002135:Calcium-Binding Proteins; D000252:Calcium-Transporting ATPases; D002155:Calsequestrin; D000099211:Phospholamban